🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19

mBio(2021)10.1128/mbio.03372-20Source: DataRank Database

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 is a research paper published in mBio (2021). On theSindex it has a DataRank of 0. It has been cited 87 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access87 citations

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 5.08)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Liise‐anne Pirofski,Michael J. Joyner ORCID,Arturo Casadevall ORCID

Live enrichment

PubMed:33653885 PMC:PMC8092292 OpenAlex:https://openalex.org/W3134025713

HHS | National Institutes of Health

Grant: AI052733

HHS | National Institutes of Health

Grant: AI15207

HHS | National Institutes of Health

Grant: HL059842

HHS | National Institutes of Health

Grant: NIH R01AI123654

HHS | National Institutes of Health

Grant: NIH R01AI143453

HHS | National Institutes of Health

Grant: NCATS 3UL1TR002556-04S1

HHS | Biomedical Advanced Research and Development Authority

Grant: 75A50120C00096

HHS | National Institutes of Health

Grant: 5R35HL139854

NIAID NIH HHS

Grant: DP1 AI152073

NIAID NIH HHS

Grant: R01 AI143453

NHLBI NIH HHS

Grant: R35 HL139854

NIAID NIH HHS

Grant: R01 AI123654

NCATS NIH HHS

Grant: UL1 TR002556

NIAID NIH HHS

Grant: R01 AI052733

NHLBI NIH HHS

Grant: R01 HL059842

National Institutes of Health

Grant: 5R01AI052733-03

Biology of Fungal Melanin

National Institutes of Health

Grant: 5R01HL059842-22

Synergy of Host Defense Mechanisms in the Lung

National Institutes of Health

Grant: 5R01AI143453-03

Antibodies, B cells and resistance to human cryptococcosis

National Institutes of Health

Grant: 5R01AI123654-03

Antibody therapy for pneumococcal disease

National Institutes of Health

Grant: 5R35HL139854-05

Variant Hemoglobin and Cardiorespiratory Regulation in Humans

National Institutes of Health

Grant: 3UL1TR002556-04S1

Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa

FWCI

5.08

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.03372-20

publisherhttps://doi.org/10.1128/mbio.03372-20

publisherhttps://journals.asm.org/doi/pdf/10.1128/mBio.03372-20

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33653885

repositoryhttps://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19COVID-19 SerotherapyAntibodies, ViralHumansImmunization, PassivePandemics

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyRelevance (law)Antibody therapyMedicineAntibodyPandemicBetacoronavirusImmunologyCoronavirus InfectionsSars virusInfectious disease (medical specialty)DiseaseOutbreakMonoclonal antibodyPathologyPolitical scienceAntibody FunctionConvalescent PlasmaCovid-19Immunization, PassiveHumansMinireviewAntibodies, ViralMicrobiologyPandemicsQR1-502COVID-19 Serotherapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being